POP-OUT | CLOSE

An Information Portal to 107049 Biological Macromolecular Structures

HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
Sequence Clustering and Redundancy Reduction Results
1G9N
Cluster # 1 Members. Sequence cutoff: 50% Cluster size: 3188 sequences | showing only first 1000 cluster members
Rank   PDB id Entity id Chains Description Details Taxonomy EC Number
Select for download / view details OR: Select two chains for comparison
  Download      Details  
1 4NZU 1 L 13PL heavy chain Fab 9606  
2 4NZU 2 H 13PL light chain Fab 9606  
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
5 1MEX 1 L Fab 29G12 light chain 10090  
6 1MEX 2 H Fab 29G12 heavy chain 10090  
7 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090  
8 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090  
9 4BUH 1 A, B CLONE M0418 SCFV 9606  
10 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606  
11 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606  
12 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090  
13 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090  
14 2XZC 1 H FAB A.17 HEAVY CHAIN 9606  
15 2XZC 2 L FAB A.17 LIGHT CHAIN 9606  
16 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090  
17 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090  
18 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090  
19 1RUP 2 H immunoglobulin igg2a, light chain fab 10090  
20 1RUK 1 L immunoglobulin igg2a, light chain fab 10090  
21 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090  
22 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606  
23 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606  
24 2VXV 1 H HUMAN IGG ABT-325 9606  
25 2VXV 2 L HUMAN IGG ABT-325 9606  
26 4GXV 1 H, I Antibody 1F1, heavy chain 9606  
27 4GXV 2 L, M Antibody 1F1, light chain 9606  
28 2VXT 1 H MURINE IGG 125-2H 10090  
29 2VXT 3 L MURINE IGG 125-2H 10090  
30 1RUM 1 L immunoglobulin igg2a, light chain fab 10090  
31 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090  
32 2XZA 1 H FAB A.17 HEAVY CHAIN 9606  
33 2XZA 2 L FAB A.17 LIGHT CHAIN 9606  
34 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
35 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090  
36 4HPY 1 H CH59 Fab heavy chain 9606  
37 4HPY 2 L CH59 Fab light chain 9606  
38 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090  
39 3T65 2 A S25-2 FAB (IGG1K) light chain 10090  
40 4JG1 1 L Fab light chain 9606  
41 4JG1 2 H Fab heavy chain 9606  
42 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606  
43 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606  
44 4O5L 1 L Fab F045-092 light chain Fab F045-092 light chain 9606  
45 4O5L 2 H Fab F045-092 heavy chain Fab F045-092 heavy chain 9606  
46 3IFL 1 L 12A11 FAB antibody light chain 10090  
47 3IFL 2 H 12A11 FAB antibody heavy chain 10090  
48 3PP4 1 H GA101 Fab heavy chain 10090  
49 3PP4 2 L GA101 Fab light chain 10090  
50 3KDM 1 A, L Immunoglobulin light chain 9606  
51 3KDM 2 B, H Immunoglobulin heavy chain 9606  
52 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
53 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
54 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
55 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
56 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090  
57 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090  
58 4PTU 1 A Antibody pn132p2C05, light chain 9606  
59 4PTU 2 B Antibody pn132p2C05, heavy chain 9606  
60 4HS6 2 A, L MRCT10.v362 Fab light chain 9606  
61 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606  
62 3IFN 1 H 12A11 FAB antibody heavy chain 10090  
63 3IFN 2 L 12A11 FAB antibody light chain 10090  
64 4TOY 1 H 35O22 Fab Heavy chain 9606  
65 4TOY 2 L 35O22 Fab Light chain 9606  
66 3NPS 2 B S4 FAB HEAVY CHAIN 9606  
67 3NPS 3 C S4 FAB LIGHT CHAIN 9606  
68 1RUR 1 L immunoglobulin 13G5, light chain fab 10090  
69 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090  
70 4M5Y 1 H, I Fab 5J8 heavy chain 9606  
71 4M5Y 2 L, M Fab 5J8 light chain 9606  
72 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090  
73 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090  
74 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090  
75 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090  
76 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
77 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
78 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
79 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606  
80 3NTC 1 L Fab light chain 10090  
81 3NTC 2 H Fab heavy chain 10090  
82 4NWU 1 H APE1551 Ab Fab heavy chain 9606  
83 4NWU 2 L APE1551 Ab Fab light chain 9606  
84 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
85 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
86 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090  
87 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090  
88 4NZR 1 H PGT135 heavy chain Fab 9606  
89 4NZR 2 L PGT135 light chain Fab 9606  
90 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986  
91 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986  
92 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090  
93 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090  
94 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
95 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
96 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090  
97 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606  
98 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606  
99 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
100 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
101 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
102 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
103 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
104 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
105 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606  
106 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606  
107 3QQ9 1 C, L 101F LIGHT CHAIN 10090  
108 3QQ9 2 D, H 101F HEAVY CHAIN 10090  
109 3OZ9 1 L Fab NC-1 kappa light chain 10090  
110 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090  
111 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606  
112 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606  
113 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606  
114 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606  
115 3G5Y 1 A 175 light chain 10090  
116 3G5Y 2 B 175 heavy chain 10090  
117 4N8C 1 H, I Heavy chain of monoclonal antibody 10090  
118 4N8C 2 L, M Light chain of monoclonal antibody 10090  
119 4HGW 1 A Antibody Fab fragment, light chain 10090  
120 4HGW 2 B Antibody Fab fragment, heavy chain 10090  
121 1NLB 1 L antibody 19D9D6 light chain 10090  
122 1NLB 2 H antibody 19D9D6 heavy chain 10090  
123 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
124 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
125 3VFG 1 L 3F8 Light Chain 10090  
126 3VFG 2 H 3F8 Heavy Chain 10090  
127 3QRG 1 L Fab light chain 9606  
128 3QRG 2 H Fab heavy chain Fd fragment 9606  
129 4LLY 2 B, D light chain Clambda 9606  
130 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
131 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090  
132 4K23 1 H anti-uPAR antibody, heavy chain 10090  
133 4K23 2 L anti-uPAR antibody, light chain 10090  
134 3NCJ 1 L Fab15 Mut8 light chain 9606  
135 3NCJ 2 H Fab15 Mut8 heavy chain 9606  
136 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
137 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
138 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090  
139 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090  
140 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090  
141 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090  
142 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
143 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
144 4M61 1 A, C Fab A52 light chain 10090  
145 4M61 2 B, D Fab A52 heavy chain 10090  
146 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
147 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
148 1UM5 1 L Antibody 21H3 L chain 10090  
149 1UM5 2 H Antibody 21H3 H chain 10090  
150 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606  
151 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606  
152 4NWT 1 L APE1531 Ab Fab light chain 9606  
153 4NWT 2 H APE1531 Ab Fab heavy chain 9606  
154 3WHX 1 A mAb Fab H fragment 10090  
155 3WHX 2 B mAb Fab L fragment 10090  
156 3NA9 1 L Fab15 light chain 9606  
157 3NA9 2 H Fab15 heavy chain 9606  
158 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
159 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
160 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
161 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
162 4LRI 1 A, B MSL-109 Light Chain 9606  
163 4LRI 2 C, P MSL-109 Heavy Chain 9606  
164 4JN2 1 A, L anti dabigatran Fab 10090  
165 4JN2 2 B, H anti dabigatran Fab 10090  
166 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090  
167 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090  
168 4JFZ 1 L Fab light chain 9606  
169 4JFZ 2 H Fab heavy chain 9606  
170 3WIF 1 A mAb Fab H fragment 10090  
171 3WIF 2 B mAb Fab L fragment 10090  
172 3MBX 1 L X836 LIGHT CHAIN 10090  
173 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090  
174 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606  
175 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606  
176 4HHA 1 A Fab KE5 Fab fragment KE5 9606  
177 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606  
178 4RGO 2 H 14G8 heavy chain Fab 10090  
179 4RGO 3 L 14G8 light chain Fab 10090  
180 3NAA 1 L Fab15 Mut5 light chain 9606  
181 3NAA 2 H Fab15 Mut5 heavy chain 9606  
182 1Q0X 1 L Fab 9B1, light chain 10090  
183 1Q0X 2 H Fab 9B1, heavy chain 10090  
184 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090  
185 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
186 4WUK 1 H CH65 heavy chain 9606  
187 4WUK 2 L CH65 light chain 9606  
188 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
189 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
190 4HPO 1 H CH58 Fab heavy chain 9606  
191 4HPO 2 L CH58 Fab light chain 9606  
192 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606  
193 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606  
194 4PUB 1 H DX-2930 HEAVY CHAIN 9606  
195 4PUB 2 L DX-2930 LIGHT CHAIN 9606  
196 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090  
197 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090  
198 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090  
199 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090  
200 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
201 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
202 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090  
203 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
204 3UYR 1 H antibody Fab heavy chain 10090  
205 3UYR 2 L antibody Fab light chain 10090  
206 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090  
207 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090  
208 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
209 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090  
210 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606  
211 3OAZ 2 K, L Fab 2G12, light chain 9606  
212 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090  
213 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
214 1ZAN 1 L Fab AD11 Light Chain 10116  
215 1ZAN 2 H Fab AD11 Heavy Chain 10116  
216 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090  
217 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090  
218 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090  
219 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090  
220 1RZF 1 L Fab E51 light chain 9606  
221 1RZF 2 H Fab E51 heavy chain 9606  
222 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544  
223 4KTE 2 L GE148 Light Chain Fab 9544  
224 4JG0 1 L Fab light chain 9606  
225 4JG0 2 H Fab heavy chain 9606  
226 3EO0 1 A, C GC-1008 Fab Light Chain 10090  
227 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090  
228 4FQI 3 H antibody CR9114 heavy chain Fab 9606  
229 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606  
230 4JHA 1 H D25 antigen-binding fragment heavy chain 9606  
231 4JHA 2 L D25 light chain 9606  
232 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
233 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
234 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606  
235 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606  
236 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090  
237 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090  
238 4DGV 1 H HCV1 Heavy Chain Fab 9606  
239 4DGV 2 L HCV1 Light Chain 9606  
240 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
241 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
242 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090  
243 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090  
244 1YNL 1 L Ig gamma light chain 10090  
245 1YNL 2 H Ig gamma heavy chain 10090  
246 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090  
247 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
248 3UMT 1 A scFv heavy chain and light chain 10090  
249 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090  
250 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090  
251 4NUJ 1 A PGT152 light chain 9606  
252 4NUJ 2 B PGT152 heavy chain 9606  
253 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090  
254 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090  
255 1RUA 1 L immunoglobulin igg2a, light chain fab 10090  
256 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090  
257 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606  
258 3U2S 2 B, L PG9 light chain 9606  
259 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090  
260 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090  
261 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090  
262 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
263 4NUG 1 L PGT151 light chain 9606  
264 4NUG 2 H PGT151 heavy chain 9606  
265 3IU4 1 H chP3 Fab heavy chain 10090  
266 3IU4 2 L chP3 Fab light chain 10090  
267 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
268 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
269 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606  
270 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606  
271 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090  
272 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090  
273 1P7K 1 A, L antibody light chain FAB 10090  
274 1P7K 2 B, H antibody heavy chain FAB 10090  
275 3RVV 2 C 4C1 - light chain 10090  
276 3RVV 3 D 4C1 - heavy chain 10090  
277 3P0Y 2 H Fab DL11 heavy chain 9606  
278 3P0Y 3 L Fab DL11 light chain 9606  
279 4NPY 1 A, L germline PGT121 light chain Fab 9606  
280 4NPY 2 B, H germline PGT121 heavy chain Fab 9606  
281 2YPV 2 H FAB 12C1 10090  
282 2YPV 3 L FAB 12C1 10090  
283 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606  
284 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606  
285 4JY5 1 L PGT122 light chain Fab 9606  
286 4JY5 2 H PGT122 heavy chain Fab 9606  
287 3NAC 1 L Fab15 Mut7 light chain 9606  
288 3NAC 2 H Fab15 Mut7 heavy chain 9606  
289 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
290 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090  
291 1Q72 1 L Fab M82G2, Light chain 10090  
292 1Q72 2 H Fab M82G2, Heavy chain 10090  
293 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606  
294 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606  
295 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090  
296 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090  
297 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090  
298 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
299 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
300 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090  
301 4DGY 1 H HCV1 Heavy Chain Fab 9606  
302 4DGY 2 L HCV1 Light Chain 9606  
303 3T77 1 A S25-2 FAB (IGG1K) light chain 10090  
304 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090  
305 3MXW 2 L 5E1 light chain 9606  
306 3MXW 3 H 5E1 heavy chain 9606  
307 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630  
308 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630  
309 3EO9 1 L Efalizumab Fab fragment, light chain 9606  
310 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606  
311 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090  
312 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090  
313 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090  
314 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090  
315 3C6S 1 A, C, E, G Fab F22-4 light chain 10090  
316 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090  
317 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090  
318 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090  
319 4JM4 1 H PGT 135 Heavy Chain Fab 9606  
320 4JM4 2 L PGT 135 Light Chain Fab 9606  
321 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
322 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090  
323 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090  
324 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090  
325 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
326 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
327 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090  
328 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090  
329 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606  
330 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606  
331 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606  
332 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
333 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
334 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606  
335 2FX7 1 L Fab 4E10 Light Chain 9606  
336 2FX7 2 H Fab 4E10 Heavy Chain 9606  
337 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606  
338 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606  
339 3WFH 1 A mAb Fab H fragment 10090  
340 3WFH 2 B mAb Fab L fragment 10090  
341 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913  
342 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913  
343 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
344 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606  
345 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
346 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090  
347 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
348 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090  
349 3RVW 2 C 4C1 - light chain 10090  
350 3RVW 3 D 4C1 - heavy chain 10090  
351 3D85 1 A FAB of antibody 7G10, light chain light chain 9606  
352 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606  
353 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090  
354 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090  
355 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
356 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090  
357 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090  
358 4JN1 2 L anti-dabigatran Fab1, light chain 10090  
359 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090  
360 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090  
361 4G5Z 1 H canakinumab antibody fragment heavy chain 9606  
362 4G5Z 2 L canakinumab antibody fragment light chain 9606  
363 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606  
364 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606  
365 2OK0 2 L Fab ED10 light chain 10090  
366 2OK0 3 H Fab ED10 heavy chain 10090  
367 3SOB 1 L antibody light chain 9606  
368 3SOB 3 H antibody heavy chain 9606  
369 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090  
370 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090  
371 2IH3 1 A FAB Heavy Chain 10090  
372 2IH3 2 B FAB Light Chain 10090  
373 4KQ3 1 L CNTO3186 light chain Fab 9606  
374 4KQ3 2 H CNTO3186 heavy chain Fab 9606  
375 4JFX 1 A, L Fab light chain 9606  
376 4JFX 2 B, H Fab heavy chain 9606  
377 3SGE 1 I, L Light Chain 10090  
378 3SGE 2 H, J Heavy Chain 10090  
379 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090  
380 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090  
381 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
382 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606  
383 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606  
384 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606  
385 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090  
386 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090  
387 1JGU 1 L Antibody Light Chain 10090  
388 1JGU 2 H Antibody Heavy Chain 10090  
389 4I77 1 H Lebrikizumab heavy chain Fab 9606  
390 4I77 2 L Lebrikizumab light chain Fab 9606  
391 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606  
392 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606  
393 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986  
394 4O4Y 2 H 2095-2 heavy chain 9986  
395 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
396 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
397 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
398 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
399 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031  
400 4GLR 3 I, K anti-ptau light chain light chain 9031  
401 4HJG 1 A Trastuzumab light chain 9606  
402 4HJG 2 B Trastuzumab heavy chain 9606  
403 4M43 1 L Fragment antigen-binding 523-11 light chain 10090  
404 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090  
405 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606  
406 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606  
407 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090  
408 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090  
409 3FN0 1 L Fab Z13e1 light chain 9606  
410 3FN0 2 H Fab Z13e1 heavy chain 9606  
411 4OSU 1 H SM5-1 Fab Heavy Chain 9606  
412 4OSU 2 L SM5-1 Fab Light Chain 9606  
413 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090  
414 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090  
415 1T2Q 1 L Fab NNA7 Heavy Chain 10090  
416 1T2Q 2 H Fab NNA7 Light Chain 10090  
417 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090  
418 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090  
419 4MAU 1 L C2244 light chain SEE REMARK 999 10090  
420 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090  
421 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090  
422 3LEX 2 B, L 11f10 Antibody Light Chain 10090  
423 1OP3 1 K, L FAB 2G12, light chain light chain 9606  
424 1OP3 2 H, M FAB 2G12, heavy chain heavy chain 9606  
425 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
426 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
427 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606  
428 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606  
429 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606  
430 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606  
431 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
432 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
433 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090  
434 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090  
435 3S96 1 A, C 3B5H10 FAB heavy chain 10090  
436 3S96 2 B, D 3B5H10 FAB light chain 10090  
437 4LKX 1 A Fab fragment heavy chain 9606  
438 4LKX 2 B Fab fragment light chain 9606  
439 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090  
440 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090  
441 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606  
442 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606  
443 4FQ2 1 H Fab heavy chain 9606  
444 4FQ2 2 L Fab light chain 9606  
445 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090  
446 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090  
447 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090  
448 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090  
449 2A77 1 L Immunoglobulin Light Chain 10090  
450 2A77 2 H Immunoglobulin Heavy Chain 10090  
451 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606  
452 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606  
453 3GO1 1 L Fab 268-D, light chain 9606  
454 3GO1 2 H Fab 268-D, heavy chain 9606  
455 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090  
456 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090  
457 3QWO 1 B, L motavizumab light chain 10090  
458 3QWO 2 A, H motavizumab heavy chain 10090  
459 3CVI 1 H 25-D1.16 Heavy chain 10090  
460 3CVI 2 L 25-D1.16 Light chain 10090  
461 1PZ5 1 A Light chain of Fab (SYA/J6) 10090  
462 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090  
463 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116  
464 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116  
465 4IOI 1 A Trastuzumab light chain 9606  
466 4IOI 2 B Trastuzumab heavy chain 9606  
467 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090  
468 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090  
469 4OKV 1 A, C heavy chain of 8H7 mAb 10090  
470 4OKV 2 B, D light chain of 8H7 mAb 10090  
471 1JGV 1 L Antibody Light Chain 10090  
472 1JGV 2 H Antibody Heavy Chain 10090  
473 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606  
474 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606  
475 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090  
476 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090  
477 2ADF 2 H 82D6A3 IgG FAB 10090  
478 2ADF 3 L 82D6A3 IgG FAB 10090  
479 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090  
480 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090  
481 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544  
482 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544  
483 1UM4 1 L Antibody 21H3 L chain 10090  
484 1UM4 2 H Antibody 21H3 H chain 10090  
485 4RBP 1 K, L Fab 2G12 light chain 9606  
486 4RBP 2 H, M Fab 2G12 heavy chain 9606  
487 3I75 1 A Antibody heavy chain 10090  
488 3I75 2 B Antibody light chain 10090  
489 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606  
490 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606  
491 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606  
492 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606  
493 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090  
494 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090  
495 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090  
496 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090  
497 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090  
498 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090  
499 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
500 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090  
501 3OAY 1 K, L Fab 2G12, light chain 9606  
502 3OAY 2 H, M Fab 2G12, heavy chain 9606  
503 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090  
504 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090  
505 1A3L 1 L IMMUNOGLOBULIN FAB 13G5 (LIGHT CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
506 1A3L 2 H IMMUNOGLOBULIN FAB 13G5 (HEAVY CHAIN) IMMUNOGLOBULIN FAB FRAGMENT 10090  
507 1YEJ 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
508 1YEJ 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
509 4GMT 1 L, M Fab S139/1 light chain 10090  
510 4GMT 2 H, I Fab S139/1 heavy chain 10090  
511 3ZKM 2 C, H FAB HEAVY CHAIN 9606  
512 3ZKM 3 D, L FAB LIGHT CHAIN 10090  
513 1FNS 1 L IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, LIGHT CHAIN 10090  
514 1FNS 2 H IMMUNOGLOBULIN NMC-4 IGG1 FAB FRAGMENT, HEAVY CHAIN 10090  
515 3HNS 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
516 3HNS 2 L CS-35 Fab Light Chain Light Chain 10090  
517 1KEL 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
518 1KEL 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
519 4DCQ 1 A 3B5H10 FAB Light Chain 10090  
520 4DCQ 2 B 3B5H10 FAB Heavy Chain 10090  
521 3TCL 1 A, H CH04 Heavy Chain Fab 9606  
522 3TCL 2 B, L CH04 Light Chain Fab 9606  
523 3QOT 1 L B3 (IGKV4-1) light chain 9606  
524 3QOT 2 H 1-69 (IGHV1-69) heavy chain FD 9606  
525 4OJF 1 H Humanised 3D6 Fab Heavy Chain 10090  
526 4OJF 2 L Humanised 3D6 Fab Light Chain 10090  
527 1N0X 1 L, M IMMUNOGLOBULIN LIGHT CHAIN 9606  
528 1N0X 2 H, K IMMUNOGLOBULIN HEAVY CHAIN 9606  
529 2FAT 1 L FAB ATN-615, light chain 10090  
530 2FAT 2 H FAB ATN-615, heavy chain 10090  
531 1RUL 1 L immunoglobulin igg2a, light chain fab 10090  
532 1RUL 2 H immunoglobulin igg2a, heavy chain fab 10090  
533 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
534 1T3F 2 B Huzaf antibody heavy chain The source is engineered human constant and framework regions with CDRs from mouse 9606  
535 4H88 2 H POM1 FAB CHAIN H 10090  
536 4H88 3 L POM1 FAB CHAIN L 10090  
537 1UM6 1 L antibody 21h3, L chain 10090  
538 1UM6 2 H antibody 21h3, H chain 10090  
539 3H0T 1 A Fab fragment, Light chain 9606  
540 3H0T 2 B Fab fragment, Heavy chain 9606  
541 2AK1 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
542 2AK1 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
543 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
544 1S3K 2 H HU3S193 Fab fragment, heavy chain murine complementarity determining regions grafted onto human framework and constant sequences 10090  
545 3HNV 1 H CS-35 Fab Heavy Chain Heavy Chain 10090  
546 3HNV 2 L CS-35 Fab Light Chain Light Chain 10090  
547 3LEY 1 H 6a7 Antibody Heavy Chain 10090  
548 3LEY 2 L 6a7 Antibody Light Chain 10090  
549 1YEI 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING DOMAIN 10090  
550 1YEI 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING DOMAIN 10090  
551 3QPQ 1 C, E, I, L C1068 light chain 10090  
552 3QPQ 2 D, F, H, J C1068 heavy chain 10090  
553 3GJF 4 K, L Antibody light chain 9606  
554 3GJF 5 H, M Antibody heavy chain 9606  
555 3UJJ 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
556 3UJJ 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 4025 9606  
557 2HFF 1 A, L CB2 Fab, light chain 9606  
558 2HFF 2 B, H CB2 Fab, heavy chain 9606  
559 4M7K 1 L 10H10 light chain SEE REMARK 999 10090  
560 4M7K 2 H 10H10 heavy chain FD, SEE REMARK 999 10090  
561 1NDG 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-8 light chain 10090  
562 1NDG 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-8 10090  
563 3OKD 1 A S25-39 Fab (IgG1k) light chain 10090  
564 3OKD 2 B S25-39 Fab (IgG1k) heavy chain 10090  
565 2IPT 1 L IgG2a Fab fragment Heavy Chain 10090  
566 2IPT 2 H IgG2a Fab fragment Light Chain Kappa 10090  
567 1SBS 1 H MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
568 1SBS 2 L MONOCLONAL ANTIBODY 3A2 FAB FRAGMENT 10090  
569 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
570 1VGE 2 H TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606  
571 4MA3 1 A, L C2095 light chain SEE REMARK 999 9986  
572 4MA3 2 B, H C2095 heavy chain FD, SEE REMARK 999 9986  
573 2FBJ 1 L IGA-KAPPA J539 FAB (LIGHT CHAIN) 10090  
574 2FBJ 2 H IGA-KAPPA J539 FAB (HEAVY CHAIN) 10090  
575 1RUQ 1 L immunoglobulin 13G5 light chain fab 10090  
576 1RUQ 2 H immunoglobulin 13G5 heavy chain fab 10090  
577 2HKF 1 L Immunoglobulin Light chain Fab fragment 10090  
578 2HKF 2 H Immunoglobulin Heavy chain Fab fragment 10090  
579 4M6N 1 L CNTO1959 light chain 9606  
580 4M6N 2 H CNTO1959 heavy chain FD 9606  
581 1YEC 1 L IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
582 1YEC 2 H IGG2A FAB FRAGMENT (D2.3) CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 10090  
583 3UYP 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090  
584 6FAB 1 L IGG1-KAPPA 36-71 FAB (LIGHT CHAIN) 10090  
585 6FAB 2 H IGG1-KAPPA 36-71 FAB (HEAVY CHAIN) 10090  
586 3L5X 1 L H2L6 LIGHT CHAIN 9606  
587 3L5X 2 H H2L6 HEAVY CHAIN 9606  
588 2YMX 1 H FAB ANTIBODY HEAVY CHAIN VARIABLE DOMAIN 10090  
589 2YMX 2 L FAB ANTIBODY LIGHT CHAIN VARIABLE DOMAIN 10090  
590 2NXY 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
591 2NXY 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
592 2R8S 2 L Fab light chain 10090  
593 2R8S 3 H Fab heavy chain 10090  
594 4HKZ 1 A Trastuzumab light chain 9606  
595 4HKZ 2 B Trastuzumab heavy chain 9606  
596 3GKZ 1 A anti-methamphetamine single chain Fv 10090  
597 1R3J 1 A Antibody Fab fragment light chain 10090  
598 1R3J 2 B Antibody Fab fragment heavy chain 10090  
599 1MFB 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
600 1MFB 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
601 1RIU 1 L Fab M82G2, Light Chain 10090  
602 1RIU 2 H Fab M82G2, Heavy Chain 10090  
603 3OKK 1 A S25-39 Fab (IgG1k) light chain 10090  
604 3OKK 2 B S25-39 Fab (IgG1k) heavy chain 10090  
605 1MFE 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
606 1MFE 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
607 4M6M 1 L CNTO1959 light chain 9606  
608 4M6M 2 H CNTO1959 heavy chain FD 9606  
609 3BPC 1 A Fab, antibody fragment (IgG1k), light chain 10090  
610 3BPC 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
611 4OCS 1 L CAP256-VRC26.10 light chain Fab 9606  
612 4OCS 2 H CAP256-VRC26.10 heavy chain Fab 9606  
613 3SO3 2 B A11 FAB light chain 9606  
614 3SO3 3 C A11 FAB heavy chain 9606  
615 2YK1 1 H FAB FRAGMENT, HEAVY CHAIN 9606  
616 2YK1 2 L FAB FRAGMENT, LIGHT CHAIN 9606  
617 3IDG 1 A 2F5 Fab light chain 9606  
618 3IDG 2 B 2F5 Fab heavy chain 9606  
619 2AJX 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090  
620 2AJX 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090  
621 3RU8 2 H Antibody b12, Heavy Chain 9606  
622 3RU8 3 L Antibody b12, Light Chain 9606  
623 1KN2 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
624 1KN2 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
625 1KN4 1 L IG ANTIBODY D2.3 (LIGHT CHAIN) 10090  
626 1KN4 2 H IG ANTIBODY D2.3 (HEAVY CHAIN) 10090  
627 1MFC 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
628 1MFC 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
629 1NQB 1 A, C SINGLE-CHAIN ANTIBODY FRAGMENT VH DOMAIN RESIDUES 2 - 120, VL DOMAIN RESIDUES 121 - 233 10090  
630 2MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
631 3OAU 1 H Fab 2G12, heavy chain Fab 9606  
632 3OAU 2 L Fab 2G12, light chain 9606  
633 2BRR 1 H, Y MN20B9.34 ANTI-P1.4 ANTIBODY, FAB HEAVY CHAIN 10090  
634 2BRR 2 L, X MN20B9.34 ANTI-P1.4 ANTIBODY, FAB LIGHT CHAIN 10090  
635 1LGV 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
636 3TNN 1 A, C, E, H Fab heavy chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
637 3TNN 2 B, D, F, L Fab light chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5 9606  
638 3TJE 1 L Fab E09, light chain 9606  
639 3TJE 2 H Fab E09, heavy chain 9606  
640 3HZV 1 A S73-2 Fab (IgG1k) light chain 10090  
641 3HZV 2 B S73-2 Fab (IgG1k) heavy chain 10090  
642 1NBZ 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090  
643 1NBZ 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090  
644 3LS5 1 L Light chain of antibody Fab fragment 10090  
645 3LS5 2 H Heavy chain of antibody Fab fragment 10090  
646 3FO9 1 A, L Immunoglobulin IGG2A - light chain light chain of 33F12 Fab' fragment 10090  
647 3FO9 2 B, H Immunoglobulin IGG2A - heavy chain heavy chain of 33F12 Fab' fragment 10090  
648 4FZE 1 L N26_i1 Fab light chain 9606  
649 4FZE 2 H N26_i1 Fab heavy chain 9606  
650 1E4W 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
651 1E4W 2 L TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
652 3U0W 1 H Fab Heavy Chain, Ig gamma-1 chain C region chimera of Fab Heavy Chain from mouse, Ig gamma-1 chain C region from human 10090  
653 3U0W 2 L Fab Light Chain, Ig kappa chain C region chimera of Fab Light Chain from mouse, Ig kappa chain C region from human 10090  
654 4JO1 1 L, M monoclonal anti-HIV-1 gp120 V3 antibody R56 light chain Fab 9986  
655 4JO1 2 H, I monoclonal anti-HIV-1 gp120 V3 antibody R56 heavy chain Fab 9986  
656 2O5X 1 L chimeric antibody Fab 1E9-DB3 light chain 10090  
657 2O5X 2 H chimeric antibody Fab 1E9-DB3 heavy chain 10090  
658 4HIE 1 A Fab 023.102 9606  
659 4HIE 2 B Antibody 023.102 9606  
660 1FL3 1 A, H BLUE FLUORESCENT ANTIBODY (19G2)-HEAVY CHAIN FAB FRAGMENT 10090  
661 1FL3 2 B, L BLUE FLUORESCENT ANTIBODY (19G2)-LIGHT CHAIN FAB FRAGMENT 10090  
662 4LEX 1 L FAB HEAVY CHAIN 10090  
663 4LEX 2 H FAB LIGHT CHAIN 10090  
664 3QEG 1 H Fab fragment of human anti-HIV antibody N12-i2, heavy chain Fab heavy chain 9606  
665 3QEG 2 L Fab fragment of human anti-HIV antibody N12-i2, light chain Fab light chain 9606  
666 3SE9 2 H Heavy chain of antibody VRC-PG04 Antigen binding fragement of heavy chain 9606  
667 3SE9 3 L Light chain of antibody VRC-PG04 antibody light chain 9606  
668 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606  
669 1CE1 2 H PROTEIN (CAMPATH-1H:HEAVY CHAIN) FAB 9606  
670 1Q0Y 1 L Fab 9B1, Light chain 10090  
671 1Q0Y 2 H Fab 9B1, Heavy chain 10090  
672 3EYS 1 L If kappa light chain 10090  
673 3EYS 2 H PFA1 Fab Heavy Chain 10090  
674 3WE6 1 A mAb Fab H fragment 10090  
675 3WE6 2 B mAb Fab L fragment 10090  
676 12E8 1 L, M IGG1-KAPPA 2E8 FAB (LIGHT CHAIN) FAB FRAGMENT 10090  
677 12E8 2 H, P IGG1-KAPPA 2E8 FAB (HEAVY CHAIN) FAB FRAGMENT 10090  
678 1A3R 1 L IGG2A 8F5 FAB (LIGHT CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
679 1A3R 2 H IGG2A 8F5 FAB (HEAVY CHAIN) FAB FRAGMENT (PAPAIN DIGESTION) 10090  
680 3ZL4 1 H A17 ANTIBODY FAB FRAGMENT HEAVY CHAIN 9606  
681 1HIL 1 A, C IGG2A-KAPPA 17/9 FAB (LIGHT CHAIN) 10090  
682 1HIL 2 B, D IGG2A-KAPPA 17/9 FAB (HEAVY CHAIN) 10090  
683 2NY2 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
684 2NY2 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
685 1F58 1 L PROTEIN (IGG1 ANTIBODY 58.2 (LIGHT CHAIN)) 10090  
686 1F58 2 H PROTEIN (IGG1 ANTIBODY 58.2 (HEAVY CHAIN)) 10090  
687 1QKZ 2 H ANTIBODY FAB 10090  
688 1QKZ 3 L ANTIBODY FAB 10090  
689 2G60 1 L anti-FLAG M2 Fab light chain 10090  
690 2G60 2 H anti-FLAG M2 Fab heavy chain 10090  
691 4GQP 1 H Anti-METH scFv 10090  
692 4KMT 1 L light chain O12/KAPPA Fab 9606  
693 4KMT 2 H heavy chain 5-51/CNTO888/IGG1 Fab 9606  
694 2FR4 2 A, L antibody light chain FAB antigen-binding fragment 10090  
695 2FR4 3 B, H antibody heavy chain FAB antigen-binding fragment 10090  
696 4H0H 1 B 2D10 scFv 10090  
697 3NZH 1 L 5F6 LIGHT CHAIN 10090  
698 3NZH 2 H 5F6 HEAVY CHAIN 10090  
699 1RHH 1 A, C Fab X5, light chain 9606  
700 1RHH 2 B, D Fab X5, heavy chain 9606  
701 2Q76 1 A, C Fab F10.6.6 fragment Light Chain domain VL and CL 10090  
702 2Q76 2 B, D Fab F10.6.6 fragment Heavy Chain domain VH and CH1 10090  
703 1TJG 1 L FAB 2F5 Light Chain 9606  
704 1TJG 2 H FAB 2F5 Heavy Chain 9606  
705 1YEF 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
706 1YEF 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
707 1YEG 1 L IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
708 1YEG 2 H IGG2A FAB FRAGMENT STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) 10090  
709 4LLW 2 B, D light chain Clambda 9606  
710 3IFO 1 A, H 10D5 FAB antibody heavy chain 10090  
711 3IFO 2 B, L 10D5 FAB antibody light chain 10090  
712 1SM3 1 L SM3 ANTIBODY FAB FRAGMENT 10090  
713 1SM3 2 H SM3 ANTIBODY FAB FRAGMENT 10090  
714 4OT1 2 H SM5-1 Fab Heavy Chain 9606  
715 4OT1 3 L SM5-1 Fab Light Chain 9606  
716 4JPI 1 A, H Putative VRC01 germline Fab heavy chain 9606  
717 4JPI 2 B, L Putative VRC01 germline Fab light chain 9606  
718 4M7J 1 H S25-26 Fab (IgG1k) heavy chain 10090  
719 4M7J 2 L S25-26 Fab (Igg1k) light chain 10090  
720 1UYW 1 H, M FAB ANTIBODY HEAVY CHAIN 10090  
721 1UYW 2 L, N FAB ANTIBODY LIGHT CHAIN 10090  
722 2XQY 2 G, J A13-D6.3 MONOCLONAL ANTIBODY HEAVY CHAIN OF FAB FRAGMENT 10090  
723 2XQY 3 K, L A13-D6.3 MONOCLONAL ANTIBODY LIGHT CHAIN OF FAB FRAGMENT 10090  
724 3O6K 1 L 11H6H1 Fab' light chain 10090  
725 3O6K 2 H 11H6H1 Fab' heavy chain 10090  
726 3C5S 1 A, C Fab F22-4 light chain 10090  
727 3C5S 2 B, D Fab F22-4 heavy chain 10090  
728 1RZ7 1 L Fab 48d light chain 9606  
729 1RZ7 2 H Fab 48d heavy chain 9606  
730 1RZG 1 A, C Fab 412d light chain 9606  
731 1RZG 2 B, D Fab 412d heavy chain 9606  
732 1GPO 1 L, M ANTIBODY M41 FAB FRAGMENT 10090  
733 1GPO 2 H, I ANTIBODY M41 FAB FRAGMENT 10090  
734 3QOS 1 A, L B3 (IGKV4-1) light chain 9606  
735 3QOS 2 B, H 3-23 (IGHV3-23) heavy chain FD 9606  
736 2HVK 1 A Antibody Fab heavy chain 10090  
737 2HVK 2 B Antibody Fab light chain 10090  
738 1MJJ 1 A, L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090  
739 1MJJ 2 B, H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090  
740 3PGF 2 H SAB Heavy Chain 9606  
741 3PGF 3 L SAB Light Chain 9606  
742 2QHR 1 H 13F6-1-2 Fab fragment heavy chain 10090  
743 2QHR 2 L 13F6-1-2 Fab fragment V lambda x light chain 10090  
744 1IQD 1 A HUMAN MONOCLONAL BO2C11 FAB LIGHT CHAIN 9606  
745 1IQD 2 B HUMAN MONOCLONAL BO2C11 FAB HEAVY CHAIN 9606  
746 1BJM 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN NA/K SO4 9606  
747 1P2C 1 A, D light chain anti-lysozyme antibody F10.6.6 10090  
748 1P2C 2 B, E heavy chain VH+CH1 anti-lysozyme antibody F10.6.6 10090  
749 2NY4 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
750 2NY4 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
751 4NJ9 1 L 8B10 light chain 10090  
752 4NJ9 2 H 8B10 heavy chain 10090  
753 1ORS 1 A 33H1 Fab light chain 10090  
754 1ORS 2 B 33H1 Fab heavy chain 10090  
755 4G6F 1 B, H 10E8 Heavy Chain Fragment of Antigen Binding 9606  
756 4G6F 2 D, L 10E8 Light Chain Fragment of Antigen Binding 9606  
757 1MLB 1 A IGG1-KAPPA D44.1 FAB (LIGHT CHAIN) 10090  
758 1MLB 2 B IGG1-KAPPA D44.1 FAB (HEAVY CHAIN) 10090  
759 2ZKH 1 L Monoclonal TN1 FAB light chain 9606  
760 2ZKH 2 H Monoclonal TN1 FAB heavy chain 9606  
761 3OJD 1 A Fab V2D2 Light chain 10090  
762 3OJD 2 B Fab V2D2 Heavy chain 10090  
763 2NY3 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
764 2NY3 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
765 1DCL 1 A, B MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER 9606  
766 3ZKN 2 C, H FAB HEAVY CHAIN 10090  
767 3ZKN 3 D, L FAB LIGHT CHAIN 10090  
768 1LO0 1 L, X If kappa light chain Fab fragment 10090  
769 1LO0 2 H, Y Ig gamma 2a heavy chain 10090  
770 35C8 1 L IGG 5C8 FAB 10090  
771 35C8 2 H IGG 5C8 FAB 10090  
772 1MIE 1 L IMMUNOGLOBULIN MS5-393 Fab fragment, LIGHT CHAIN 10090  
773 1MIE 2 H IMMUNOGLOBULIN MS5-393 Fab fragment, HEAVY CHAIN 10090  
774 4DVB 1 A, H Fab fragment of pro-uPA antibody mAb-112 10090  
775 4DVB 2 B, L Fab fragment of pro-uPA antibody mAb-112 10090  
776 2B1H 1 L Fab 2219, light chain light chain 9606  
777 2B1H 2 H Fab 2219, heavy chain heavy chain 9606  
778 3MA9 2 H Fab8066 FAB ANTIBODY FRAGMENT, Heavy Chain 9606  
779 3MA9 3 L Fab8066 FAB ANTIBODY FRAGMENT, Light Chain 9606  
780 1RFD 1 L Fab M82G2, Light Chain 10090  
781 1RFD 2 H Fab M82G2, Heavy Chain 10090  
782 1MFD 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090  
783 1MFD 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090  
784 2QQN 2 H Antibody heavy chain 9606  
785 2QQN 3 L Antibody light chain 9606  
786 3RVT 1 C Fab fragment of 4C1 antibody - light chain 10090  
787 3RVT 2 D Fab fragment of 4C1 antibody - heavy chain 10090  
788 1JVK 1 A, B IMMUNOGLOBULIN LAMBDA LIGHT CHAIN 9606  
789 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
790 3L5W 2 B, H C836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090  
791 3MCG 1 1, 2 IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN) 9606  
792 2NY1 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
793 2NY1 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
794 4OGY 2 H, M DX-2930 HEAVY CHAIN 9606  
795 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606  
796 3THM 1 L Fab EP6b_B01, light chain 9606  
797 3THM 2 H Fab EP6b_B01, heavy chain 9606  
798 3EOT 1 H FAB FRAGMENT, HEAVY CHAIN 10090  
799 3EOT 2 L FAB FRAGMENT, LIGHT CHAIN 10090  
800 4MA7 2 H POM1 heavy chain Fab 10090  
801 4MA7 3 L POM1 light chain Fab 10090  
802 1LO2 1 L, X If kappa light chain Fab fragment 10090  
803 1LO2 2 H, Y Ig gamma 2a heavy chain 10090  
804 1UZ6 1 E, L, M, V IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090  
805 1UZ6 2 F, H, P, W IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090  
806 2D03 1 L anti-glycophorin A type N immunoglobulin light chain 10090  
807 2D03 2 H anti-glycophorin A type N immunoglobulin heavy chain 10090  
808 3UJT 1 H, I Ab-52 heavy chain Fab fragment 10090  
809 3UJT 2 L, M Ab-52 light chain Fab fragment 10090  
810 3O6L 1 L 11H6H1 Fab' light chain 10090  
811 3O6L 2 H 11H6H1 Fab' heavy chain 10090  
812 3E8U 1 H Fab 106.3 heavy chain 10090  
813 3E8U 2 L Fab 106.3 light chain 10090  
814 1C5B 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090  
815 1C5B 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090  
816 4JZN 1 A, C, I Anti-HCV E2 Fab HC84-1 heavy chain 9606  
817 4JZN 2 B, D, P Anti-HCV E2 Fab HC84-1 light chain 9606  
818 2CMR 2 H D5 9606  
819 2CMR 3 L D5 9606  
820 3GNM 1 L JAA-F11 Fab Antibody Fragment, Light Chain 10090  
821 3GNM 2 H JAA-F11 Fab Antibody Fragment, Heavy Chain 10090  
822 2FD6 2 L L chain of Fab of ATN-615 anti-uPAR antibody 10090  
823 2FD6 3 H H chain of Fab of ATN-615 anti-uPAR antibody 10090  
824 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606  
825 4R4B 2 B, D, F, H FAB 2.2C HEAVY CHAIN 9606  
826 1TET 1 L IGG1 TE33 FAB (LIGHT CHAIN) 10090  
827 1TET 2 H IGG1 TE33 FAB (HEAVY CHAIN) 10090  
828 4BZ2 2 H FAB 2D73 HEAVY CHAIN 10090  
829 4BZ2 3 L FAB 2D73 LIGHT CHAIN 10090  
830 2AEP 2 H FAB heavy chain 10090  
831 2AEP 3 L FAB light chain 10090  
832 4MSW 1 A ANTIBODY FAB FRAGMENT HEAVY CHAIN 10090  
833 4MSW 2 B ANTIBODY FAB FRAGMENT LIGHT CHAIN 10090  
834 4FQH 1 A, H antibody CR9114 heavy chain Fab 9606  
835 4FQH 2 B, L antibody CR9114 light chain Fab Lambda 9606  
836 3GRW 2 L Fab light chain 9606  
837 3GRW 3 H Fab heavy chain 9606  
838 4KTD 1 H GE136 Heavy Chain Fab Fab fragment 9544  
839 4KTD 2 L GE136 Light Chain Fab 9544  
840 3LS4 1 L Light chain of antibody Fab fragment 10090  
841 3LS4 2 H Heavy chain of antibody Fab fragment 10090  
842 1D5I 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
843 1D5I 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
844 4Q2Z 1 A, H Heavy chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
845 4Q2Z 2 B, L Light chain of Fab fragment of HIV vaccine-elicited CD4bs-directed antibody 9544  
846 1OSP 1 L FAB 184.1 10090  
847 1OSP 2 H FAB 184.1 10090  
848 1F8T 1 L ANTIBODY FAB FRAGMENT (LIGHT CHAIN) 10090  
849 1F8T 2 H ANTIBODY FAB FRAGMENT (HEAVY CHAIN) 10090  
850 4LSP 2 H HEAVY CHAIN OF ANTIBODY VRC-CH31 9606  
851 4LSP 3 L LIGHT CHAIN OF ANTIBODY VRC-CH31 9606  
852 2R2H 1 A Fab, antibody fragment (IgG1k), light chain 10090  
853 2R2H 2 B Fab, antibody fragment (IgG1k), heavy chain 10090  
854 1DQJ 1 A ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090  
855 1DQJ 2 B ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090  
856 1RIV 1 L Fab M82G2, Light Chain 10090  
857 1RIV 2 H Fab M82G2, Heavy Chain 10090  
858 3QCU 1 H, I LT3015 antibody Fab fragment, heavy chain 9606  
859 3QCU 2 L, M LT3015 antibody Fab fragment, light chain 9606  
860 1Q9K 1 A S25-2 Fab (IgG1k) light chain Light Chain kappa 10090  
861 1Q9K 2 B S25-2 Fab (IgG1k) heavy chain Heavy Chain g1 10090  
862 4OTX 1 L, M N203 light chain Fab 10090  
863 4OTX 2 H, I N203 heavy chain Fab 10090  
864 4EOW 1 H MB007 human IgG1 Fab fragment heavy chain 9606  
865 4EOW 2 L MB007 IgG1 Fab fragment light chain 9606  
866 1K4C 1 A antibody Fab fragment heavy chain 10090  
867 1K4C 2 B antibody Fab fragment light chain 10090  
868 2NXZ 3 C ANTIBODY 17B, LIGHT CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
869 2NXZ 4 D ANTIBODY 17B, HEAVY CHAIN ANTIGEN-BINDING FRAGMENT, FAB 9606  
870 1E4X 1 H TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
871 1E4X 2 I TAB2 MURINE FAB-FRAGMENT IG KAPPA HEAVY CHAIN 10090  
872 1E4X 3 L, M TAB2 MURINE FAB-FRAGMENT IG KAPPA LIGHT CHAIN 10090  
873 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606  
874 1UJ3 2 B IgG Fab heavy chain anti-tissue-factor antibody hATR-5 Fab 9606  
875 3CLF 1 L Fab light chain 10090  
876 3CLF 2 H Fab heavy chain 10090  
877 4HIX 1 H Humanized 3D6 Fab heavy chain 10090  
878 4HIX 2 L Humanized 3D6 Fab light chain 10090  
879 4LKC 1 A Fab fragment of PCSK9 antibody 9606  
880 4LKC 2 B Fab fragment of PCSK9 antibody 9606  
881 1MHH 1 A, C Fab, light chain 10090  
882 1MHH 2 B, D Fab, heavy chain 10090  
883 4GW5 1 A, C Fab Light Chain 10090  
884 4GW5 2 B, D Fab Heavy Chain 10090  
885 1W72 4 H, I HYB3 HEAVY CHAIN FAB FRAGMENT, RESIDUES 1-211 9606  
886 1W72 5 L, M HYB3 LIGHT CHAIN FAB FRAGMENT, RESIDUES 1-228 9606  
887 4OM1 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
888 4OM1 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
889 4KZD 1 H BL3-6 Fab antibody, heavy chain 10090  
890 4KZD 2 L BL3-6 Fab antibody, light chain 10090  
891 4HCR 1 H, M PF-547659 heavy chain 9606  
892 4HCR 2 L, N PF-547659 light chain 9606  
893 4CNI 1 A, H OLOKIZUMAB HEAVY CHAIN, FAB PORTION FAB PORTION 9606  
894 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606  
895 1C1E 1 L CATALYTIC ANTIBODY 1E9 (LIGHT CHAIN) FAB FRAGMENT 10090  
896 1C1E 2 H CATALYTIC ANTIBODY 1E9 (HEAVY CHAIN) FAB FRAGMENT 10090  
897 1TJH 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
898 1TJH 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
899 1YEK 1 L PROTEIN (IG ANTIBODY D2.3 (LIGHT CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
900 1YEK 2 H PROTEIN (IG ANTIBODY D2.3 (HEAVY CHAIN)) ANTIGEN BINDING FRAGMENT 10090  
901 4HIH 1 A, C Fab 023.102 9606  
902 4HIH 2 B, D Antibody 023.102 9606  
903 3FFD 1 A Monoclonal antibody, heavy chain, Fab fragment 10090  
904 3FFD 2 B Monoclonal antibody, light chain, Fab fragment 10090  
905 1D6V 1 L CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (LIGHT CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
906 1D6V 2 H CHIMERIC GERMLINE PRECURSOR OF OXY-COPE CATALYTIC ANTIBODY AZ-28 (HEAVY CHAIN) THE PROTEIN WAS PRODUCED AS A CHIMERIC FAB FRAGMENT. THE VARIABLE DOMAINS (CHAINS A,L 1-107, CHAINS B,H 1-113) ARE MURINE. THE CONSTANT DOMAINS (CHAINS A, L 108-211 AND CHAINS B,H 113-214) ARE HUMAN. CHIMERIC FAB FRAGMENT 10090  
907 1YY8 1 A, C Cetuximab Fab Light chain 10090  
908 1YY8 2 B, D Cetuximab Fab Heavy chain 10090  
909 1DZB 1 A, B SCFV FRAGMENT 1F9 SEE REMARK 400 10090  
910 4ONG 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090  
911 4ONG 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090  
912 4ETQ 1 A, H anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, heavy chain Fab 10090  
913 4ETQ 2 B, L anti-vaccinia D8L antigen murine monoclonal IgG2a antibody LA5, light chain Fab 10090  
914 3QPX 1 L Fab C2507 light chain 10116  
915 3QPX 2 H Fab C2507 heavy chain 10116  
916 3U4E 2 A, H PG9 Heavy Chain 9606  
917 3U4E 3 B, L PG9 Light Chain 9606  
918 2R0Z 1 L IgG2a Fab fragment light chain light chain 10090  
919 2R0Z 2 H IgG2a Fab fragment heavy chain, Fd portion Fd portion of heavy chain 10090  
920 3DRQ 1 A 2F5 Fab' light chain 9606  
921 3DRQ 2 B 2F5 Fab' heavy chain 9606  
922 3NIG 3 E, H Monoclonal antibody 10E5 heavy chain 10090  
923 3NIG 4 F, L Monoclonal antibody 10E5 light chain 10090  
924 3UZE 1 A, B Variable domains of murine anti-dengue Mab 4E11 Single chain variable fragment 10090  
925 1TJI 1 L anti-HIV-1 antibody 2F5 Light Chain 9606  
926 1TJI 2 H anti-HIV-1 antibody 2F5 Heavy Chain 9606  
927 1KEM 1 L 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
928 1KEM 2 H 28B4 FAB THIS PROTEIN IS A FAB FRAGMENT PRODUCED UPON THE DIGESTION OF FULL-LENGTH MURINE MONOCLONAL ANTIBODY BY PAPAIN VARIABLE REGIONS OF LIGHT AND HEAVY CHAINS 10090  
929 25C8 1 L IGG 5C8 FAB 10090  
930 25C8 2 H IGG 5C8 FAB 10090  
931 3QNX 1 A Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN 9606  
932 3QNX 2 B Fab fragment of IMMUNOGLOBULIN A1 HEAVY CHAIN 9606  
933 3PHQ 1 A S64-4 Fab (IgG1) light chain 10090  
934 3PHQ 2 B S64-4 Fab (IgG1) heavy chain 10090  
935 3G5V 1 A 806 light chain 10090  
936 3G5V 2 B 808 heavy chain 10090  
937 4OLZ 2 H Antigen binding fragment of heavy chain: Antibody VRC01 9606  
938 4OLZ 3 L Antigen binding fragment of light chain: Antibody VRC01 9606  
939 4GSD 1 L H5.3 Fab Light Chain 9606  
940 4GSD 2 H H5.3 Fab Heavy Chain 9606  
941 3UZV 2 B anti-dengue Mab 4E11 Single chain variable fragment 10090  
942 3D0V 1 A 2F5 Fab heavy chain 9606  
943 3D0V 2 B 2F5 Fab light chain 9606  
944 2C1P 1 A, L IGK-C PROTEIN 10090  
945 2C1P 2 B, H IGH-4 PROTEIN FAB-FRAGMENT 10090  
946 3BJL 1 A, B LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER CRYSTALLIZED IN AMMONIUM SULFATE 9606  
947 4O51 1 A, C, E, L QAA-2095-2 light chain 9986  
948 4O51 2 B, D, F, H QAA-2095-2 heavy chain 9986  
949 3S34 1 L 1121B Fab light chain 10090  
950 3S34 2 H 1121B Fab heavy chain 10090  
951 1GAF 1 L CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
952 1GAF 2 H CHIMERIC 48G7 FAB BOTH FAB CHAINS ARE DERIVED FROM THE MATURE (HYBRIDOMA LINE) ANTIBODY. THE LIGHT CHAIN CONSISTS OF THE VJ VARIABLE DOMAIN FROM MOUSE AND THE C(KAPPA) CONSTANT REGION FROM HUMAN. THE HEAVY CHAIN CONSISTS OF THE VDJ VARIABLE DOMAIN FROM MOUSE AND THE C(H1) CONSTANT REGION FROM HUMAN VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
953 2P7T 1 A FAB-A 10090  
954 2P7T 2 B FAB-B 10090  
955 3MOD 2 L ANTI-HIV-1 ANTIBODY 2F5 LIGHT CHAIN 9606  
956 3MOD 3 H ANTI-HIV-1 ANTIBODY 2F5 HEAVY CHAIN 9606  
957 4HXA 1 L 13D9 FAB LIGHT CHAIN 10090  
958 4HXA 2 H 13D9 FAB HEAVY CHAIN 10090  
959 1NDM 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-26 light chain 10090  
960 1NDM 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-26 10090  
961 2IQA 1 A, L IgG2a Fab fragment PFA2 Kappa light chain 10090  
962 2IQA 2 B, H IgG2a Fab fragment PFA2 heavy chain 10090  
963 1H0D 1 A ANTIBODY FAB FRAGMENT, LIGHT CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
964 1H0D 2 B ANTIBODY FAB FRAGMENT, HEAVY CHAIN HINGE REGION OBSERVED IN THE FAB FRAGMENT 9606  
965 2F5B 1 L PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) FAB' 9606  
966 2F5B 2 H PROTEIN (ANTIBODY 2F5 (HEAVY CHAIN)) FAB' 9606  
967 3MNW 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
968 3MNW 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and human Fc 10090  
969 1IL1 1 A monoclonal antibody G3-519 (heavy chain) FAB FRAGMENT 10090  
970 1IL1 2 B monoclonal antibody G3-519 (light chain) FAB FRAGMENT 10090  
971 1NC2 1 A, C MONOCLONAL ANTIBODY 2D12.5, LAMBDA LIGHT CHAIN Fab 10090  
972 1NC2 2 B MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN Fab 10090  
973 1NC2 3 D MONOCLONAL ANTIBODY 2D12.5, IGG1 GAMMA HEAVY CHAIN Fab 10090  
974 1U8I 1 A ANTIBODY 2F5 (LIGHT CHAIN) 9606  
975 1U8I 2 B ANTIBODY 2F5 (HEAVY CHAIN) 9606  
976 2VDR 4 H MONOCLONAL ANTIBODY 10E5 HEAVY CHAIN 10090  
977 2VDR 5 L MONOCLONAL ANTIBODY 10E5 LIGHT CHAIN 10090  
978 1IND 1 L IGG1-LAMBDA CHA255 FAB (LIGHT CHAIN) 10090  
979 1IND 2 H IGG1-LAMBDA CHA255 FAB (HEAVY CHAIN) 10090  
980 2RCS 1 L IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 10090  
981 2RCS 2 H IMMUNOGLOBULIN 48G7 GERMLINE FAB VARIABLE DOMAINS OF LIGHT AND HEAVY CHAINS AND CONSTANT DOMAINS OF LIGHT AND HEAVY CHAINS 9606  
982 1JGL 1 L Ig kappa-chain 10090  
983 1JGL 2 H Ig gamma-1-chain residues 1-215 10090  
984 4G6J 2 H heavy chain of antibody binding fragment of canakinumab heavy chain of antibody binding fragment of canakinumab 9606  
985 4G6J 3 L light chain of antibody binding fragment of canakinumab light chain of antibody binding fragment of canakinumab 9606  
986 2AJ3 1 A, C, E Fab m18, Light Chain 9606  
987 2AJ3 2 B, D, F Fab m18, Heavy Chain 9606  
988 1SY6 1 L OKT3 Fab light chain fab fragment light chain 10090  
989 1SY6 2 H OKT3 Fab heavy chain fab fragment heavy chain 10090  
990 3T3P 3 E, H Monoclonal antibody 10E5 heavy chain 10090  
991 3T3P 4 F, L Monoclonal antibody 10E5 light chain 10090  
992 1EMT 1 L IGG ANTIBODY (LIGHT CHAIN) FAB FRAGMENT 10090  
993 1EMT 2 H IGG ANTIBODY (HEAVY CHAIN) FAB FRAGMENT 10090  
994 3IDI 1 A 2F5 Fab light chain 9606  
995 3IDI 2 B 2F5 Fab heavy chain 9606  
996 3G6A 1 A, L CNTO607 Fab Light chain 9606  
997 3G6A 2 B, H CNTO607 Fab Heavy chain 9606  
998 1CLO 1 L A5B7 MONOCLONAL ANTIBODY ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 ANTIGEN BINDING FRAGMENT, FAB 10090  
999 1CLO 2 H A5B7 MONOCLONAL ANTIBODY ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7 ANTIGEN BINDING FRAGMENT, FAB 10090  
1000 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630  
 
Sequence Clusters for the Sequence Entities in PDB 1G9N
Entity #1: Chains: G - ENVELOPE GLYCOPROTEIN GP120 protein, length: 313 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 6 7 4203
95% 6 7 4796
90% 8 10 3088
70% 22 29 1085
50% 22 29 1145
40% 22 29 1170
30% 22 31 1068
Entity #2: Chains: C - T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 21 30 843
95% 25 35 947
90% 25 35 965
70% 25 35 998
50% 25 35 1043
40% 25 35 1069
30% 25 35 1048
Entity #3: Chains: L - ANTIBODY 17B, LIGHT CHAIN protein, length: 214 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 2 31627
95% 19 21 1668
90% 271 380 5
70% 971 1339 3
50% 2298 3188 1
40% 2299 3189 1
30% 2675 3771 1
Entity #4: Chains: H - ANTIBODY 17B, HEAVY CHAIN protein, length: 229 [Blast  ]
Cluster Sequence Similarity Cutoff Rank   Nr. of chains in Cluster Cluster Nr.  
100% 2 2 30651
95% 19 21 1666
90% 19 21 1713
70% 1107 1537 2
50% 2299 3188 1
40% 2300 3189 1
30% 2676 3771 1
 

Documentation

Click here for more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB.